Essential technologies help keep this website secure and working. With your permission, we use optional analytics to understand what works and improve the website. You can browse and enquire without accepting optional cookies, and change your choices at any time. See our Cookie & Similar Technologies Notice.
Digital clinical safety governance
Clinical Safety Officer Services
Appoint a named CSO or strengthen your existing clinical safety capability. Clinical safety leadership, evidence and ongoing support for HealthTech and NHS teams, under an agreed mandate.
Named clinical safety leadership, coordinated with governance and programme delivery.
You need to appoint a named Clinical Safety Officer for a product or deployment
02
Your existing CSO needs specialist capacity for evidence, reviews or change
03
Your HealthTech business is preparing clinical safety evidence for NHS market entry
04
Your NHS or care organisation needs DCB0160 deployment and local workflow assurance
05
Releases, AI-enabled functionality or integrations are changing the clinical risk profile
06
You need a defined-scope DCB0129/DCB0160 review or evidence-development engagement
The service
Appoint a CSO or strengthen the one you have
A CSO role needs active clinical involvement, not just a signature at the end. IG-Smart offers a named appointment within agreed clinical risk management arrangements, or specialist support alongside an existing CSO. Defined-scope assessment and evidence-development engagements are available through Clinical Safety Consultancy. The manufacturer or deploying organisation remains accountable for its systems and use; appointment and clinical review responsibilities are distinct from organisational risk acceptance and deployment authority.
Appointment and decision rights
An agreed clinical mandate. Clear organisational decision rights.
Formal CSO appointment
IG-Smart can provide the named practitioner; your organisation confirms the appointment, mandate and governance arrangements.
Clinical review and approval
The appointed CSO performs the clinical review and approvals required by the applicable standard and documented appointment. In support-only engagements, your existing CSO retains those duties.
Residual-risk acceptance
Authorised individuals in your organisation accept residual clinical risk and release decisions.
Organisational accountability
Accountability for clinical safety stays with the manufacturer or deploying organisation.
Two related services
Which service fits?
Choose Clinical Safety Officer Services for a named appointment or ongoing support for an existing CSO. Choose Clinical Safety Consultancy for defined-scope assessment, evidence development or implementation support. Appointment provision can form part of an engagement where expressly agreed.
Appointment or ongoing support · You are hereClinical Safety Officer ServicesA named CSO within an agreed mandate, or additional specialist capacity alongside your existing CSO. Client accountability and decision rights remain explicit.
DCB0129
Manufacturer responsibilities
Applies to organisations manufacturing health IT systems: clinical risk management across development, release, maintenance and change of the product.
DCB0160
Deployment and use responsibilities
Applies to health and care organisations deploying and using those systems: local configuration, workflows, training and operational change.
Supplier evidence does not automatically satisfy a deploying organisation’s obligations. Applicability depends on the product, intended use and deployment context; the current published standards remain the operative requirements while NHS England’s review continues.
Already have an appointed CSO?
This service supports their clinical-risk-management processes, safety evidence, change reviews and governance reporting. Your appointed CSO retains clinical review and approval responsibilities.
Need a formally appointed CSO?
IG-Smart can provide a named senior clinical safety professional for an agreed CSO appointment. Suitability, current eligibility, availability, scope and responsibilities are checked before appointment. Your organisation retains accountability and authorised risk-acceptance and deployment decisions.
Why IG-Smart
Clinical safety connected to the rest of your assurance
Clinical safety rarely fails in isolation. Our wider governance, risk and assurance work means clinical risk evidence stays consistent with privacy, security, supplier and board reporting. These are the connections we draw on; each engagement’s scope is agreed separately, and not every capability below is included in CSO support.
Governance and accountability
Clear decision rights, escalation routes and RACI, so clinical safety sits inside organisational governance rather than beside it.
Service lead Michael Abtar’s experience includes serving as Clinical Safety Officer for Royal Brompton & Harefield NHS Foundation Trust. Read the RBHT case study
An appropriately qualified senior professional to fulfil the expressly agreed appointment and clinical risk management role.
Clinical safety governance
Clear responsibilities, decision rights, escalation and reporting across clinical, product, technical and executive teams.
DCB0129/DCB0160 activities
Clinical risk management and evidence work appropriate to manufacture or deployment and use; the two responsibilities remain distinct.
Safety evidence development
Gap analysis, hazard assessment and development or review of the agreed safety case, hazard log and clinical risk management records.
NHS assurance coordination
Clinical safety evidence connected to relevant DTAC and wider governance workstreams where commissioned.
Release and continuing assurance
Advice, evidence updates and review of changes or incidents within the agreed scope and cadence.
How the engagement runs
From an agreed mandate to ongoing assurance
The engagement model determines who performs clinical review, what is delivered and how continuing support is organised.
1
Assess
Review intended use, applicable responsibilities, existing evidence and whether you need an appointed CSO, support or defined-scope consultancy.
2
Build
Agree the named practitioner where required, check suitability and eligibility, document decision rights and develop the agreed clinical safety evidence.
3
Manage
Provide clinical safety leadership or support under the agreed mandate, coordinating product, clinical and programme stakeholders.
4
Assure
Review hazards, controls and safety evidence against the applicable standard and documented appointment; escalate unresolved issues to authorised decision-makers.
5
Improve
Use release reviews, incident learning and periodic reassessment to update evidence and working arrangements where commissioned.
→ Clinical review and approvals follow the applicable standard and documented appointment. Unresolved issues follow the agreed escalation routes; organisational decisions remain with authorised decision-makers. Every engagement follows IG-Smart’s structured delivery approach: Assess → Build → Manage → Assure → Improve. Explore how we work
What each stage produces
01
Assess
Agreed scope, appointment model and evidence gaps.
02
Build
Appointment and responsibility records; agreed safety documentation.
03
Manage
Maintained evidence, action tracking and change-review records.
04
Assure
Clinical review, assurance findings and decision-support evidence.
05
Improve
Updated evidence and prioritised improvement actions.
Engagement options
Appointed CSO services or support for your existing CSO
Appointed Clinical Safety Officer Services
A named senior professional for an agreed CSO role
Suitability, current eligibility and availability checked before appointment
Mandate, clinical responsibilities, approval authority and escalation documented
Clinical Safety Officer Support
Governance, risk management, evidence-development and assurance capacity
Ongoing support or a focused requirement
Your existing CSO continues the agreed clinical review role
For defined-scope assessment, evidence development or implementation support, see Clinical Safety Consultancy through the service selector above. Consultancy is separately scoped and quoted; it does not automatically create a CSO appointment.
What you receive
What evidence will be produced?
Outputs are agreed for the product, deployment and lifecycle stage. The example below is not a live assessment, completed safety case, clinical approval or guarantee of compliance.
Appointment and accountability recordIllustrative structure
Appointment and accountability recordIllustrative data — not client data
Illustrative Appointment and accountability record
Activity
Appointed-CSO model
Existing-CSO support
Client responsibility
CSO mandate
Named IG-Smart practitioner; terms agreed
Existing appointed CSO
Confirm appointment and governance arrangements
Clinical review
Applicable standard and documented appointment
Existing CSO; IG-Smart supports evidence
Provide information and authorised escalation routes
Risk acceptance / deployment
Clinical advice and review within mandate
Evidence and decision support
Authorised organisational decision-makers
Illustrative output
Appointment and accountability record
Responsibility map
Distinguishes an IG-Smart appointment from support for an existing CSO, showing the clinical duties and organisational decision routes to document.
What it helps you see
Mandate
Clinical review
Decision authority
Likely format
Role and decision-rights record
Illustrative structure — not a client document. Exact outputs and formats depend on the agreed scope.
Scope boundaries
Clinical leadership with explicit accountability
Agreed IG-Smart responsibilities
Named CSO provision where expressly agreed
Clinical safety governance and risk assessment
Clinical Safety Case Report, Hazard Log and Clinical Risk Management File where scoped
Change review and ongoing advice where commissioned
Responsibilities and limits
Your organisational, operational and regulatory accountability
Authorised residual-risk acceptance, release and deployment decisions
No guarantee of NHS procurement acceptance, regulatory approval or a harm-free system
Appointment eligibility, capacity, scope and fees must be confirmed; no automatic appointment from an enquiry
Scope, deliverables and assumptions are agreed in writing before work begins.
Relevant evidence
Related NHS & HealthTech evidence
Selected published engagements demonstrating relevant governance, assurance and NHS/HealthTech capability. They are not presented as Clinical Safety Officer engagements unless the underlying approved case evidence expressly states that.
Named client · Healthcare / NHS
Royal Brompton & Harefield NHS Foundation Trust
Three-year managed service: Information Governance, data quality, Payment by Results, trust-wide information security and clinical systems safety, reporting to the board-level SIRO
Three-year managed IG, data quality, security & clinical systems safety service · reporting to the board-level SIRO
The approved Royal Brompton & Harefield engagement documents a managed NHS governance and clinical systems safety service. Michael Abtar's practitioner experience is attributed separately; the case is not used to infer another practitioner's registration or current availability.
Embedded governance and clinical-safety support since start-up
NHS AI Toolkit, DSPT, DTAC and clinical-safety governance from start-up
The approved Clini-Hub case describes clinical safety case reports and DCB0129/DCB0160 support alongside NHS and AI governance. The client's compliance statement is client-reported, not an independent certification.
Specialist expertise, coordinated around your requirement
Subject-matter expertise is paired with a clear client and programme contact from initial scoping through delivery.
Clinical Safety Officer and health informatics specialist
Himanshu Desai
MSc, MBA, MRPharmS
Specialist expertise in health informatics, prescribing and medication-management systems. Has attended NHS England’s Digital Clinical Safety – Practitioner course; his certificate of attendance is available on request.
Service lead — clinical safety governance and multidisciplinary assurance
Michael Abtar
LLB (Hons), PG.Dip.Law, Cert. DPO
Leads the service, drawing on his experience as Clinical Safety Officer at Royal Brompton & Harefield and coordinating clinical safety with information governance, privacy, cyber assurance and organisational accountability.
Himanshu Desai attended NHS England’s Digital Clinical Safety – Practitioner course. His certificate of attendance is available on request.
Clinical safety training
Digital Clinical Safety – Practitioner
Provider
NHS England
Evidence
Certificate of attendance signed by the Clinical Director for Patient Safety; available upon request
Course attendance is training, not a separate professional certification. Professional membership and postnominals do not establish current statutory registration or appointment eligibility; training does not imply NHS endorsement of IG-Smart.
Do DCB0129 and DCB0160 require a Clinical Safety Officer?
Yes. NHS guidance states that both standards require the organisation to nominate a Clinical Safety Officer. The CSO should be a senior clinician with current professional registration and sufficient training in clinical safety and clinical risk management.
Does IG-Smart provide an appointed Clinical Safety Officer?
Yes. IG-Smart provides appropriately qualified, named senior clinical safety professionals who can be appointed to fulfil an agreed CSO role within the client's clinical risk management arrangements. We also support organisations with an existing CSO. The named practitioner's suitability, current eligibility, availability, responsibilities and appointment terms are checked and agreed before the engagement. Appointment does not transfer the client's organisational accountability or all risk-acceptance, release and deployment decisions to IG-Smart.
Is the CSO responsible only for signing the safety case?
No. The role should provide active clinical safety leadership across hazard identification, risk evaluation, control review, evidence quality, change assurance, incident learning and governance reporting. A signature without adequate involvement does not create credible assurance.
How do DCB0129 and DCB0160 differ?
DCB0129 applies to manufacturers responsible for developing and maintaining health IT systems. DCB0160 applies to health organisations responsible for deployment and use. Many implementations require the supplier and deploying organisation to coordinate evidence and transferred risks.
Are the standards changing?
NHS England is reviewing DCB0129 and DCB0160. Its published standards pages currently list the 2018 releases. We check the applicable requirements when scoping an engagement.
Can CSO support help with DTAC?
Yes. Clinical safety is one of the core DTAC areas. IG-Smart can help ensure the hazard log, clinical safety case and supporting governance are coherent, current and ready for buyer scrutiny.
What does the £3,000 + VAT monthly starting investment cover?
The retained service is scoped for ongoing governance, reviews, release assurance, board reporting and incident support alongside your appointed CSO. The agreed scope, deliverables, responsibilities, available capacity and fee are confirmed in writing before work starts. The published starting investment is not a fixed number of hours, systems or releases. Onboarding, initial safety-case development and substantial remediation are quoted separately where required.
Who leads the work, and who approves clinical safety decisions?
Michael Abtar leads clinical safety governance and multidisciplinary assurance; Himanshu Desai brings health informatics and clinical safety expertise. Practitioner allocation and capacity are agreed during scoping. The appointed CSO performs the clinical review and approvals required by the applicable standard and documented appointment; in support-only engagements, your existing CSO retains those duties. Authorised organisational decision-makers retain risk-acceptance, release and deployment authority. Experience, membership and training do not establish current professional registration or appointment eligibility.
What happens when our product or deployment changes?
Releases, configuration, integrations, workflows or new intended uses may alter the clinical risk profile. Within the agreed scope, we assess change impacts, review affected hazards and controls, and update the hazard log, safety case and decision records. Unresolved issues are escalated through the documented clinical review and organisational decision routes.
Investment
Starting investment: £3,000 + VAT per month
This published starting investment applies only to retained support alongside your existing CSO. Appointed-CSO engagements are individually scoped and quoted; no appointment price is published. Capacity, responsibilities and fees are confirmed in writing. Onboarding, initial safety-case development and substantial remediation are quoted separately where required. Defined-scope consultancy is separately scoped.
Choose the right commercial model
Appointed CSO — named role, mandate and fee agreed individually
Existing-CSO support — retained support or focused additional capacity
Defined-scope consultancy — assessment, evidence or implementation requirement
Peer review — conflicts and independence assessed for the proposed reviewer and scope